7LE-23117-53459
3 vaccinations
0 coded responses
13 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 112 / NY
- Registered
- 2022-01-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2021-01-08
Dose 2 — Pfizer-BioNTech
-
2022-01-30
Dose 3 — Pfizer-BioNTech
-
2022-01-31
Registered in v-safe
-
2022-01-31
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2022-02-01
- 2022-02-02
- 2022-02-03
- 2022-02-08
- 2022-02-13
- 2022-02-20
- 2022-02-27
- 2022-03-06
- 2022-03-13
- 2022-05-01
- 2022-08-02
- 2023-02-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | No |
| 2 | 2021-01-08 | Pfizer-BioNTech | No |
| 3 | 2022-01-30 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.